These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16556474)
1. Mutant Escherichia coli enterotoxin as a mucosal adjuvant induces specific Th1 responses of CD4+ and CD8+ T cells to nasal killed-bacillus calmette-guerin in mice. Takahashi H; Sasaki K; Takahashi M; Shigemori N; Honda S; Arimitsu H; Ochi S; Ohara N; Tsuji T Vaccine; 2006 Apr; 24(17):3591-8. PubMed ID: 16556474 [TBL] [Abstract][Full Text] [Related]
2. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536 [TBL] [Abstract][Full Text] [Related]
3. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine. Ding Y; Zheng H; Feng C; Wang B; Liu C; Mi K; Cao H; Meng S Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661 [TBL] [Abstract][Full Text] [Related]
4. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine. Takamura S; Matsuo K; Takebe Y; Yasutomi Y J Immunol; 2005 Aug; 175(4):2541-7. PubMed ID: 16081827 [TBL] [Abstract][Full Text] [Related]
5. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. Dietrich J; Andersen C; Rappuoli R; Doherty TM; Jensen CG; Andersen P J Immunol; 2006 Nov; 177(9):6353-60. PubMed ID: 17056566 [TBL] [Abstract][Full Text] [Related]
6. Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Poyntz HC; Stylianou E; Griffiths KL; Marsay L; Checkley AM; McShane H Tuberculosis (Edinb); 2014 May; 94(3):226-37. PubMed ID: 24572168 [TBL] [Abstract][Full Text] [Related]
7. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice. Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737 [TBL] [Abstract][Full Text] [Related]
8. Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine. Lu X; Clements JD; Katz JM Vaccine; 2002 Jan; 20(7-8):1019-29. PubMed ID: 11803061 [TBL] [Abstract][Full Text] [Related]
9. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice. Chuang YM; Pinn ML; Karakousis PC; Hung CF Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022 [No Abstract] [Full Text] [Related]
10. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
11. Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant. You Q; Wu Y; Jiang D; Wu Y; Wang C; Wei W; Yu X; Zhang X; Kong W; Jiang C Immunol Invest; 2012; 41(4):412-28. PubMed ID: 22360290 [TBL] [Abstract][Full Text] [Related]
12. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response. Fromantin C; Jamot B; Cohen J; Piroth L; Pothier P; Kohli E J Virol; 2001 Nov; 75(22):11010-6. PubMed ID: 11602741 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli. Liang S; Hosur KB; Nawar HF; Russell MW; Connell TD; Hajishengallis G Vaccine; 2009 Jul; 27(32):4302-8. PubMed ID: 19450646 [TBL] [Abstract][Full Text] [Related]
14. Induction of cellular immunity to varicella-zoster virus glycoproteins tested with pernasal coadministration of Escherichia coli enterotoxin in mice. Tsuji T; Shiraki K; Sato H; Sasaki K; Arita M; Kato M; Takahashi T; Ochi S; Ichinose Y; Yokochi T; Asano Y J Med Virol; 2003 Mar; 69(3):451-8. PubMed ID: 12526058 [TBL] [Abstract][Full Text] [Related]
15. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555 [TBL] [Abstract][Full Text] [Related]
16. Selective expansion of perforin-positive CD8+ T cells by immature dendritic cells infected with live Bacillus Calmette-Guérin mycobacteria. Tsunetsugu-Yokota Y; Tamura H; Tachibana M; Ogata K; Honda M; Takemori T J Leukoc Biol; 2002 Jul; 72(1):115-24. PubMed ID: 12101270 [TBL] [Abstract][Full Text] [Related]
18. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the culture filtrate-specific cytotoxic T lymphocyte response induced by Bacillus Calmette-Guérin vaccination in H-2b mice. Denis O; Huygen K Int Immunol; 1999 Feb; 11(2):209-16. PubMed ID: 10069419 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle. Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]